S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)
S&P 500   4,272.62 (-0.36%)
DOW   33,316.43 (-0.57%)
QQQ   362.09 (+1.07%)
AAPL   174.09 (+1.68%)
MSFT   320.61 (+1.54%)
META   305.67 (+1.82%)
GOOGL   133.85 (+2.28%)
AMZN   129.67 (+2.01%)
TSLA   253.38 (+1.26%)
NVDA   450.62 (+3.59%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   102.91 (+0.09%)
T   14.86 (-1.07%)
F   12.35 (-0.56%)
MU   67.67 (-0.53%)
CGC   0.78 (-0.36%)
GE   109.30 (-1.13%)
DIS   81.08 (+0.04%)
AMC   7.94 (-0.63%)
PFE   33.51 (+1.03%)
PYPL   58.66 (+0.34%)
NFLX   383.45 (+1.55%)

Inspire Medical Systems (INSP) Stock Forecast, Price & News

$199.73
+1.29 (+0.65%)
(As of 11:37 AM ET)
Compare
Today's Range
$196.99
$200.31
50-Day Range
$185.07
$291.01
52-Week Range
$159.62
$330.00
Volume
133,182 shs
Average Volume
423,606 shs
Market Capitalization
$5.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$345.08

Inspire Medical Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
73.9% Upside
$345.08 Price Target
Short Interest
Healthy
4.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
1.03mentions of Inspire Medical Systems in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$822,494 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.76) to ($0.45) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.84 out of 5 stars

Medical Sector

62nd out of 969 stocks

Surgical & Medical Instruments Industry

11th out of 101 stocks


INSP stock logo

About Inspire Medical Systems (NYSE:INSP) Stock

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Price History

INSP Stock News Headlines

Nuclear Revival Creates Opportunities for Uranium
Uranium companies set to benefit from increased demand for clean energy.
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
InspireSemi Announces Final Closing of Non-Brokered Private Placement
The Latest Analyst Ratings for Inspire Medical Systems
Inspire Medical Systems earnings: here's what Wall Street expects
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Company Calendar

Last Earnings
8/01/2023
Today
10/02/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
755
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$345.08
High Stock Price Forecast
$380.00
Low Stock Price Forecast
$308.00
Forecasted Upside/Downside
+73.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$-44,880,000.00
Pretax Margin
-7.66%

Debt

Sales & Book Value

Annual Sales
$407.86 million
Book Value
$17.17 per share

Miscellaneous

Free Float
28,016,000
Market Cap
$5.82 billion
Optionable
Optionable
Beta
1.40
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Timothy P. HerbertMr. Timothy P. Herbert (Age 60)
    CEO, Pres & Director
    Comp: $1.35M
  • Mr. Richard J. BuchholzMr. Richard J. Buchholz (Age 55)
    Chief Financial Officer
    Comp: $683.2k
  • Mr. Philip J. EbelingMr. Philip J. Ebeling (Age 52)
    Chief Operating Officer
    Comp: $696.13k
  • Mr. John C. RondoniMr. John C. Rondoni (Age 43)
    Chief Technology Officer
    Comp: $576.72k
  • Mr. Randall A. Ban (Age 58)
    Chief Commercial Officer
    Comp: $759.23k
  • Dr. Charisse Y. Sparks FAAOS (Age 60)
    M.D., Chief Medical Officer
    Comp: $21.88k
  • Ms. Ezgi Yagci
    VP of Investor Relations
  • Mr. Bryan K. Phillips (Age 52)
    Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
  • Mr. Martin A. Abrams
    VP of Marketing & Customer Experience
  • Mr. Steven L. JandrichMr. Steven L. Jandrich (Age 56)
    VP of HR













INSP Stock - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price forecast for 2023?

11 Wall Street research analysts have issued 12-month price targets for Inspire Medical Systems' shares. Their INSP share price forecasts range from $308.00 to $380.00. On average, they anticipate the company's share price to reach $345.08 in the next twelve months. This suggests a possible upside of 73.9% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2023?

Inspire Medical Systems' stock was trading at $251.88 at the beginning of the year. Since then, INSP stock has decreased by 21.2% and is now trading at $198.44.
View the best growth stocks for 2023 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,180,000 shares, an increase of 14.6% from the August 31st total of 1,030,000 shares. Based on an average trading volume of 512,100 shares, the short-interest ratio is currently 2.3 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings results on Tuesday, August, 1st. The company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.10. The firm had revenue of $151.09 million for the quarter, compared to analyst estimates of $136.47 million. Inspire Medical Systems had a negative net margin of 7.81% and a negative trailing twelve-month return on equity of 8.21%. Inspire Medical Systems's revenue for the quarter was up 65.3% on a year-over-year basis. During the same period in the prior year, the business earned ($0.53) EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.00 million-$610.00 million, compared to the consensus revenue estimate of $589.63 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $198.44.

How much money does Inspire Medical Systems make?

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $5.82 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Inspire Medical Systems have?

The company employs 755 workers across the globe.

How can I contact Inspire Medical Systems?

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.

This page (NYSE:INSP) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -